Sneary Isn’t Sneering at Stem Cell Therapy: Hawaiian Man Says Stem Cells Helped His Heart December 6, 2007
Posted by TheraVitae in : Press Releases , trackbackMaui Surfer Now Off All Medications After Stem Cell Treatment
Maui, Hawaii 12/06/2007 04:35 AM GMT (TransWorldNews)
Robert Sneary, 62, living in Maui, Hawaii has always been an active man. Even a quadruple bypass for his heart in 2001 couldn’t keep him from his true love of surfing. However, in his own words, “I couldn’t do as much as I wanted to.” Robert’s weight had shot up to 280 pounds and his energy was slowly diminishing.
Robert, a retired executive at AT&T, had been researching stem cells for more than 5 years before he came across Theravitae, an international adult stem cell company that treats patients suffering from congestive heart failure, coronary artery disease, and cardiomyopathy using their Vescell stem cell treatment.
Robert said, “I had researched adult stem cells for 5 years. I knew it was going to work.”
Robert arrived in Bangkok, Thailand in January, 2006 to receive his stem cell therapy. “I was very well treated by Theravitae. The doctors were very thorough and made me feel very comfortable.”
Robert was treated with his own adult stem cells in a simple procedure, very similar to an angioplasty.
These days, almost two years after his stem cell treatment, Robert is doing great. “I can exercise more and I am down to 227 pounds. I am off all my medications which I hated to take.”
“Whatever Theravitae did, it helped. My neighbors can’t believe the change in me. I have no more pain, no more swelling in my ankle like I used to have. I would definitely recommend this and would be happy to talk to anyone about it.”
About TheraVitae:
TheraVitae is a private, multinational company focused on using stem cells from the patient’s own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, ‘VesCell’, that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease and peripheral artery disease.
VesCell — A Natural Treatment for Heart Disease and Peripheral Arterial Disease (PAD)
The body has natural ways of healing itself and the cardiovascular system is no exception. Angiogenic Cell Precursors (ACPs) originate in bone marrow and then circulate in the blood vessels. To manufacture VesCell, TheraVitae expands a small number of ACPs harvested from about 250cc of blood into a therapeutic quantity. VesCell is injected either through a coronary artery via catheter, or during surgery, directly into the heart muscle.
A key aspect of VesCell therapy is the advanced cell isolation and expansion technique that allows for the ACPs to be harvested from blood collected in a procedure similar to a common blood donation. VesCell uses a patient’s own adult stem cells to treat Heart Disease and PAD and is a viable therapeutic possibility for heart or PAD patients without any other treatment option.
